Novartis Ag (NVS) Divestments (2011 - 2026)

Novartis Ag has disclosed Divestments across 16 years of filings, most recently posting $62.0 million for Q2 2026.

• In Q2 2026, Divestments rose 663.64% year-over-year to $62.0 million; the TTM figure through Jun 2026 stood at -$19.0 million (up 99.47% YoY), while the FY2025 annual figure was -$88.0 million, down 182.24% from the prior year.
• Divestments came in at $62.0 million for Q2 2026 at Novartis Ag, up from -$2.0 million in the prior quarter.
• In the past five years, Divestments ranged from a high of $62.0 million in Q2 2026 to a low of -$3.6 billion in Q4 2024.
• Average Divestments over 5 years is -$647.8 million, with a median of -$19.0 million recorded in 2023.
• Year-over-year, Divestments slumped 44875.0% in 2024 and jumped 663.64% in 2026.
• Over 5 years, Divestments stood at -$7.0 million in 2022, then fell by 14.29% to -$8.0 million in 2023, then tumbled by 44875.0% to -$3.6 billion in 2024, then soared by 99.58% to -$15.0 million in 2025, then surged by 513.33% to $62.0 million in 2026.
• Per Business Quant data, the three most recent Divestments figures were $62.0 million in Q2 2026, -$2.0 million in Q1 2026, and -$15.0 million in Q4 2025.